Narrow search
Showing 21 - 30 of 395,102
Cover Image
Optimal price regulations in international pharmaceutical markets with generic competition
Geng, Difei; Saggi, Kamal - In: Technology transfer, foreign direct investment, and the …, (pp. 415-433). 2024
Persistent link: https://www.econbiz.de/10014431471
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Why brand drugs priced higher than generic equivalents
Iacocca, Kathleen; Sawhill, James; Zhao, Yao - In: International journal of pharmaceutical and healthcare … 9 (2015) 1, pp. 3-19
Persistent link: https://www.econbiz.de/10011302283
Cover Image
U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016
Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26
Persistent link: https://www.econbiz.de/10012182277
Cover Image
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …
Persistent link: https://www.econbiz.de/10014025576
Cover Image
Essays on the economics of pharmaceuticals
Virabhak, Suchin - 2005
Persistent link: https://www.econbiz.de/10003550944
Cover Image
Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
Conti, Rena M. - 2019
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales … cohorts; (iii) the extent of competition is greatest for the oldest molform cohorts and is smallest for the youngest molform … cohorts. With a median of one competitor, the extent of competition in the youngest molform cohort is very limited; and (iv …
Persistent link: https://www.econbiz.de/10012480138
Cover Image
Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
Conti, Rena - 2019
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales … cohorts; (iii) the extent of competition is greatest for the oldest molform cohorts and is smallest for the youngest molform … cohorts. With a median of one competitor, the extent of competition in the youngest molform cohort is very limited; and (iv …
Persistent link: https://www.econbiz.de/10012862864
Cover Image
The determinants of pricing in pharmaceuticals : are US prices really so high?
Cabrales, Antonio; Jiménez-Martín, Sergie - 2008
Persistent link: https://www.econbiz.de/10010442786
Cover Image
Non-tariff barriers and bargaining in generic pharmaceuticals
Ganapati, Sharat; McKibbin, Rebecca - 2019
Persistent link: https://www.econbiz.de/10011973614